Published in Volume
83, Issue 2 (February 1989)
J Clin Invest. 1989;83(2):698–707.
doi:10.1172/JCI113934.
Copyright ©
1989, The American Society for
Clinical Investigation.
Research Article
Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
J Jackson, R B Sim, K Whaley and C Feighery
Department of Immunology, St. James Hospital, Dublin, Ireland.
Published February 1989
C1-inhibitor (C1-Inh) is an important inhibitor of the inflammatory response and deficiency of this inhibitor, which may be hereditary or acquired, is associated with recurrent episodes of edema. Recently, an autoimmune form of angioedema has been described that is associated with functional deficiency of C1-Inh and an autoantibody that impedes C1-Inh function. In this report we describe the isolation of C1-Inh from the monocytes and plasma of a patient with autoimmune angioedema and demonstrate that the patient's monocytes secrete structurally and functionally normal C1-Inh, but show that this protein circulates in the patient's plasma in an inactive, structurally altered form. Furthermore, using analytic gel electrophoresis techniques it is demonstrated that the patient's autoantibody facilitates cleavage of normal C1-Inh, by its target proteases, to the same species of C1-Inh that is found circulating in the patient's plasma. This autoantibody facilitated cleavage of normal C1-Inh is apparently a consequence of destabilization of protease/inhibitor complexes. These findings contribute to our understanding of protease/C1-Inh interactions and document important observations on pathogenic mechanisms in autoimmune disease.
Browse pages
Click on an image below to see the page. View
PDF of the complete article